Phil Knight, co-founder and chairman of Nike, and his wife Penny gave the gift to establish a center for translational research, clinical care, professional training and outreach in heart and vascular disease.
As a collaboration between researchers and clinicians, the institute will aim to develop new cardiovascular prevention, diagnostic and treatment strategies through research and apply them to patient care as quickly as possible. The institute will also build partnerships with pharmaceutical and medical device developers to reach patients through the commercial marketplace.
Heart surgeon Albert Starr, MD, and Sanjiv Kaul, MD, head of OHSU’s Division of Cardiovascular Medicine, (pictured above) will co-direct the institute.
More Articles on Hospital Cardiology:
Community Health Network’s Indiana Heart Hospital Changes Name
3 Cardiology Employment Trends Post-Reform
Deborah Heart and Lung Center CEO Calls on Hospital to Partner Instead of Seeking Cardiac Surgery CON
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
